A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus

被引:12
作者
Chen, Hsin-Wei [1 ,2 ]
Huang, Hui-Wen [3 ]
Hu, Hui-Mei [1 ]
Chung, Han-Hsuan [1 ]
Wu, Szu-Hsien [1 ]
Chong, Pele [1 ]
Tao, Mi-Hua [3 ]
Pan, Chien-Hsiung [1 ,2 ]
机构
[1] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Kaohsiung, Miaoli County, Taiwan
[2] China Med Univ, Grad Inst Immunol, Taichung, Taiwan
[3] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
关键词
FC-GAMMA-RECEPTOR; ANTIBODY-MEDIATED PROTECTION; MONOCLONAL-ANTIBODIES; IFN-GAMMA; SUBCLASS SPECIFICITY; T-CELLS; IN-VIVO; INFECTION; IMMUNOGLOBULIN; MOUSE;
D O I
10.1099/vir.0.067280-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We demonstrated previously that immunization with a DNA vaccine expressing the Japanese encephalitis virus (JEV) envelope (E) protein conferred a high level of protection through a poorly neutralizing antibody response. Here, we further investigated the role of the IgG subclass in this antibody-dependent protection using cytokine co-immunization and cytokine-deficient mice. A significant difference in IgG2a/c but not IgG1 was observed between mice that survived or died following a lethal challenge. Correspondingly, the IgG2a/c response and protection increased in IL-4-deficient mice but decreased in IFN-gamma-deficient mice, highlighting the importance of IgG2a/c. In addition, the restoration of protection and E-specific IgG2a/c production in IFN-gamma-deficient mice by a T helper (Th) type 1-biased intramuscular immunization suggested that IgG2a/c but not IFN-gamma was the major component for protection. The failure of protection against a direct intracranial challenge indicated that IgG2a/c-mediated protection was restricted to outside the central nervous system. Consistent with this conclusion, passive transfer of E-specific antisera conferred protection only pre-exposure to JEV. Therefore, our data provided evidence that the IgG subclass plays an important role in protection against JEV, particular in poorly neutralizing E-specific antibodies, and Th1-biased IgG2a/c confers better protection than Th2-biased IgG1 against JEV.
引用
收藏
页码:1983 / 1990
页数:8
相关论文
共 46 条
[1]   MECHANISMS OF ANTIBODY-MEDIATED PROTECTION AGAINST LYMPHOCYTIC CHORIOMENINGITIS VIRUS-INFECTION - MOTHER-TO-BABY TRANSFER OF HUMORAL PROTECTION [J].
BALDRIDGE, JR ;
BUCHMEIER, MJ .
JOURNAL OF VIROLOGY, 1992, 66 (07) :4252-4257
[2]   B Cell Intrinsic MyD88 Signals Drive IFN-γ Production from T Cells and Control Switching to IgG2c [J].
Barr, Tom A. ;
Brown, Sheila ;
Mastroeni, Pietro ;
Gray, David .
JOURNAL OF IMMUNOLOGY, 2009, 183 (02) :1005-1012
[3]  
Burke D. S., 1988, JAPANESE ENCEPHALITI
[4]   Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines [J].
Chen, HW ;
Pan, CH ;
Liau, MY ;
Jou, RW ;
Tsai, CJ ;
Wu, HJ ;
Lin, YL ;
Tao, MH .
JOURNAL OF VIROLOGY, 1999, 73 (12) :10137-10145
[5]  
Chow YH, 1998, J IMMUNOL, V160, P1320
[6]   Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc γ receptor-dependent and -independent mechanisms [J].
Chung, KM ;
Nybakken, GE ;
Thompson, BS ;
Engle, MJ ;
Marri, A ;
Fremont, DH ;
Diamond, MS .
JOURNAL OF VIROLOGY, 2006, 80 (03) :1340-1351
[7]   Antibody recognition of cell surface-associated NS1 triggers Fc-γ receptor-mediated phagocytosis and clearance of West Nile virus-infected cells [J].
Chung, Kyung Min ;
Thompson, Bruce S. ;
Fremont, Daved H. ;
Diamond, Michael S. .
JOURNAL OF VIROLOGY, 2007, 81 (17) :9551-9555
[8]   Fc receptors are required in passive and active immunity to melanoma [J].
Clynes, R ;
Takechi, Y ;
Moroi, Y ;
Houghton, A ;
Ravetch, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :652-656
[9]   IGG2A RESTRICTION OF MURINE ANTIBODIES ELICITED BY VIRAL-INFECTIONS [J].
COUTELIER, JP ;
VANDERLOGT, JTM ;
HEESSEN, FWA ;
WARNIER, G ;
VANSNICK, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) :64-69
[10]  
Ding D, 2003, B WORLD HEALTH ORGAN, V81, P334